Dronedarone-induced Phototoxicity in a Patient with Atrial Fibrillation.
dronaderone
photosensitivity
rash
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
23 Sep 2019
23 Sep 2019
Historique:
entrez:
9
11
2019
pubmed:
9
11
2019
medline:
9
11
2019
Statut:
epublish
Résumé
Dronedarone is a class III antiarrhythmic agent and a potent blocker of multiple intracardiac ion channels with many electrophysical properties common with amiodarone. Oral dronedarone, 400 mg twice daily, is approved for the maintenance of normal sinus rhythm in patients with a history of atrial fibrillation (AF) or atrial flutter. It is primarily used for the maintenance of sinus rhythm in patients with paroxysmal or persistent AF or atrial flutter. Dronedarone is a relatively new therapeutic agent which is a non-iodinated congener of amiodarone and hypothesized to have far lesser side effects. Photosensitivity is an uncommon side effect of dronedarone and not much has been described in the literature. Here we describe a patient with such complication.
Identifiants
pubmed: 31700760
doi: 10.7759/cureus.5731
pmc: PMC6822562
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e5731Informations de copyright
Copyright © 2019, Datar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Br J Pharmacol. 2001 Jul;133(5):625-34
pubmed: 11429385
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669
Photochem Photobiol Sci. 2019 Jun 12;18(6):1565-1575
pubmed: 31037283